Chugai Pharmabody Research
Silvia Yang Sun is a Principal Scientist at Chugai Pharmabody Research, where contributions have been made since June 2015 after advancing through roles including Senior Scientist and Researcher. Prior experience includes positions as a Postdoctoral Research Fellow and Research Project Officer at Nanyang Technological University from June 2009 to May 2015. Education includes a Doctor of Philosophy in Molecular Genetic and Cell Biology from Nanyang Technological University, obtained in 2013, and a Bachelor of Science in Biology from the same institution in 2007. Early education was received at Raffles Junior College and Raffles Girls' School.
This person is not in the org chart
This person is not in any offices
Chugai Pharmabody Research
1 followers
In the global medical field, there are many diseases in which there are no drug or current drugs are insufficient to address the medical needs of patients. Chugai Pharmabody Research (CPR) is a subsidiary company of Chugai Pharmaceutical in Japan, a member of Roche group, and is committed to address these unmet needs by specializing in the field of antibody drug discovery utilizing proprietary antibody engineering technologies.